Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2026-03-02 @ 4:00 PM
Study NCT ID:
NCT04305327
Status:
TERMINATED
Last Update Posted:
2025-03-14
First Post:
2020-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
Sponsor:
LEO Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-05
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-10
First Submit QC Date:
None
Study First Post Date:
2020-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-18
Results First Submit QC Date:
None
Results First Post Date:
2024-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-03-14
Last Update Post Date Type:
ACTUAL